Medicare Enrolled
Dr. David Sikes, MD
Rheumatology · Zephyrhills, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sikes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sikes?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sikes
Dr. David Sikes is a rheumatology specialist in Zephyrhills, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sikes performed 163,427 Medicare services across 2,254 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sikes received a total of $19,870 from 46 pharmaceutical and/or device companies across 1074 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sikes is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in FL
$19,870 industry payments
Medicare Practice Summary
Medicare Utilization ↗163,427
Medicare services
Top 13% in FL for rheumatology
2,254
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,601 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 61,755 | $5 | $12 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
27,910 | $11 | $56 |
| Romosozumab injection (Evenity) for osteoporosis | 16,170 | $8 | $23 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
15,200 | $4 | $20 |
| Denosumab injection (Prolia/Xgeva) | 14,520 | $18 | $47 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
9,825 | $34 | $131 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
5,360 | $26 | $180 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
4,200 | $64 | $238 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
2,700 | $19 | $185 |
| Injection, benralizumab, 1 mg | 1,380 | $132 | $417 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
989 | $90 | $273 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
495 | $98 | $345 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
475 | $6 | $157 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
441 | $11 | $41 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
365 | $41 | $219 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
356 | $8 | $19 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
277 | $63 | $186 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
242 | $21 | $75 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
224 | $48 | $176 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
126 | $54 | $195 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
121 | $12 | $41 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 72 | $14 | $33 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
64 | $118 | $415 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
40 | $3 | $11 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
36 | $70 | $273 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
32 | $129 | $366 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $36 | $112 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
17 | $7 | $31 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
14 | $44 | $246 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
26.8% high complexity
72.1% medium
1.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,870
Total received (2018-2024)
Avg $2,839/year across 7 years
Top 23% in FL for rheumatology
46
Companies
1,074
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,799 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$71 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,168
2023
$3,455
2022
$3,018
2021
$2,710
2020
$2,114
2019
$3,217
2018
$3,187
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,593
Amgen Inc.
$2,078
AbbVie Inc.
$1,499
Janssen Biotech, Inc.
$1,496
UCB, Inc.
$1,417
PFIZER INC.
$1,367
AbbVie, Inc.
$1,074
ABBVIE INC.
$949
Genentech USA, Inc.
$789
Horizon Therapeutics plc
$719
E.R. Squibb & Sons, L.L.C.
$670
Lilly USA, LLC
$629
GENZYME CORPORATION
$552
Radius Health, Inc.
$453
Actelion Pharmaceuticals US, Inc.
$373
GlaxoSmithKline, LLC.
$371
AstraZeneca Pharmaceuticals LP
$313
Celgene Corporation
$255
Aurinia Pharma U.S., Inc.
$199
Johnson & Johnson Health Care Systems Inc.
$172
Alexion Pharmaceuticals, Inc.
$155
Sobi, Inc
$155
United Therapeutics Corporation
$139
Boehringer Ingelheim Pharmaceuticals, Inc.
$135
McKesson Specialty Care Distribution, LLC
$122
Horizon Pharma plc
$121
Organon LLC
$109
Hikma Pharmaceuticals USA
$107
Mallinckrodt Hospital Products Inc.
$103
Fresenius Kabi USA, LLC
$95
SANOFI-AVENTIS U.S. LLC
$89
SOBI, INC
$80
Kyowa Kirin, Inc.
$73
Mallinckrodt LLC
$59
Mallinckrodt Enterprises LLC
$51
Ferring Pharmaceuticals Inc.
$49
Sandoz Inc.
$39
Organon Llc
$38
Sebela Pharmaceuticals Inc.
$34
Janssen Scientific Affairs, LLC
$30
Bayer HealthCare Pharmaceuticals Inc.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$23
SCILEX PHARMACEUTICALS INC.
$23
Flexion Therapeutics, Inc.
$17
ASD SPECIALTY HEALTHCARE, LLC
$17
West-Ward Pharmaceuticals
$11
Top 3 companies account for 31.1% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Adempas · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · Crysvita · EUFLEXXA · EVENITY · EVUSHELD · Enbrel · FASENRA · FLUMIST QUADRIVALENT · FORTEO · HADLIMA · HUMIRA · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LEQVIO · LUPKYNIS · LYRICA · Mitigare · NO PRODUCT DISCUSSED · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · OPSUMIT · ORENCIA · ORENITRAM · Otezla · PREVNAR - 13 · Prolia · RAYOS · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYNAGIS · Strensiq · TAKHZYRO · TALTZ · TAVNEOS · TEZSPIRE · TREMFYA · TYVASO · Tavneos · Tymlos · UPTRAVI · XELJANZ · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $12 per 100 Medicare services performed
Geographic Context
Rheumatologists within 10 mi
33
Per 100K population
5.6
County median income
$67,384
Nearest hospital
Adventhealth Zephyrhills
2.7 mi
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sikes is a mixed practice specialist, with above-average Medicare volume (top 13% in FL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sikes experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Sikes performed 61,755 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sikes receive payments from pharmaceutical companies?
Yes. Dr. Sikes received a total of $19,870 from 46 companies across 1,074 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sikes's costs compare to other rheumatologists in Zephyrhills?
Dr. Sikes's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sikes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Zephyrhills
Browse rheumatologists in Zephyrhills ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology